Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, PTH's top sector exposures are Health Care ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.72% for PTH. ARKG is down -5.11% year-to-date (YTD) with -$10M in YTD flows. PTH performs better with -5.03% YTD performance, and -$3M in YTD flows. Run a side-by-side ETF comparison of ARKG and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG PTH | -3.62%-1.98% | -10.23%-6.38% | -5.11%-5.03% | +23.23%+27.22% | -2.84%+28.99% | -70.08%-12.73% |
| Flows | ARKG PTH | -$50M-$944K | -$85M-$3M | -$10M-$3M | -$210M-$13M | -$627M-$93M | -$2.79B-$491M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG PTH | +39.15%+22.13% | +44.62%+24.66% | +42.26%+24.33% | +45.19%+25.54% |
| Max drawdown | ARKG PTH | -19.50%-7.42% | -23.94%-16.12% | -51.98%-29.24% | -80.33%-50.10% |
| Max drawdown duration | ARKG PTH | 48d81d | 77d183d | 966d271d | 1822d1653d |
ARKG | PTH | |
Last sale 3/13/2026 at 1:30 PM | $26.36 | $47.18 |
| Previous close 03/12/2026 | $26.17 | $47.28 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
ARKG | PTH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
ARKG | PTH | |
|---|---|---|
| Last price | $26.36 | $47.18 |
| 1D performance | +0.73% | -0.21% |
| AuM | $1.11 B | $116.15 M |
| E/R | 0.75% | 0.72% |
ARKG | PTH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | Invesco |
| Benchmark | - | Dorsey Wright Healthcare Technical Leaders Index |
| N° of holdings | 30 | 46 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | October 12, 2006 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
